The role of fMRI in drug development
2017 · Drug Discovery Today · 64 citations
https://doi.org/10.1016/j.drudis.2017.11.012
D
David Scott
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
116
Papers
5.8K
Citations
28
h-index
39
i10-index
David Scott is an academic researcher from Concord Consortium. The author has contributed to research in topics: Dementia and Cognitive Impairment Research & Functional Brain Connectivity Studies & Pain Management and Placebo Effect. The author has an h-index of 28, co-authored 99 publications.
ORCID: 0000-0002-8054-7502Papers by this author
worksDifferences in Ki67 and c-erbB2 expression between screen-detected and true interval breast cancers.
1999 · PubMed · 49 citations
Evaluation of tau deposition using 18F-PI-2620 PET in MCI and early AD subjects—a MissionAD tau sub-study
2022 · Alzheimer s Research & Therapy · 28 citations
https://doi.org/10.1186/s13195-022-01048-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat